en

PRODUCT DETAIL

Obodence 60 mg injekčný roztok v naplnenej injekčnej striekačke

Code 9120E
MA number EU/1/24/1890/001
Product Form: sol inj 1x1 ml/60 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Samsung Bioepis NL B.V., Netherland
Therapeutic Class: 87 - VARIA I
ATC:
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BX Other drugs affecting bone structure and mineralization
M05BX04 Denosumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 12.02.2025
Validity: 12.02.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 03.03.2025
eu-flag.png sk-flag.png